Cutaneous recall reactions with systemic fluorouracil

Dermatology

Volumn 206, Issue 2, 2003, Pages 175-176

  Kirkup, M E ^a   Narayan, S ^a   Kennedy, C T C ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Actinic keratosis; Adverse drug reaction; Fluorouracil; Oesophagogastric carcinoma

Indexed keywords

BECLOMETASONE; CISPLATIN; CLOBETASONE BUTYRATE; FLUOROURACIL; RETINOID; STEROID;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CLINICAL FEATURE; CRYOTHERAPY; DIARRHEA; ERYTHEMA; ESOPHAGUS CARCINOMA; HUMAN; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PRURITUS; RASH; SKIN DISEASE; SKIN MANIFESTATION; TINNITUS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG ERUPTIONS; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; KERATOSIS; MALE; MIDDLE AGED;

EID: 0037272318     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068455     Document Type: Article

References (4)

1. Susser WS, Whitaker-Worth D, Grant-Kels JM: Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999;40:367-398.
2. Faulkson G, Schulz EJ: Skin changes in patients treated with 5-fluorouracil. Br J Dermatol 1962;74:229-236.
3. Johnson T, Rapini R, Duvic M: Inflammation of actinic keratoses from systemic chemotherapy. J Am Acad Dermatol 1987;1:192-197.
4. Korossy K, Hood A: Methotrexate reactivation of sun-burn reaction. Arch Dermatol 1981;117:310-311.